James Reese, MD
Otolaryngology/Facial Plastic Surgery · Sonora, CANPI 1538173059
Payments from drug & device makers
Across 28 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$178
- Sanofi$123
- Intersect ENT, Inc.$120
- Stryker$118
- Acclarent, Inc$54
- Regeneron Healthcare Solutions, Inc.$28
- plus $65 from 3 others
What the payments were for
- Food & beverage$685100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 7 | $178 |
| Sanofi | 3 | $123 |
| Intersect ENT, Inc. | 4 | $120 |
| Stryker | 5 | $118 |
| Acclarent, Inc | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Pentax Of America, Inc. | 3 | $26 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $17 |
How this compares
$685 in reported general payments places this provider in the 35th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $51,060 |
| Ipratropium Bromide | 85 | $4,273 |
| Fluticasone Propionate | 32 | $819 |
| Ofloxacin | 11 | $465 |
| Pilocarpine Hcl | 11 | $456 |
| Mometasone Furoate | 13 | $270 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Sonora
- Daniel DuboseSonora$1K
- Vasu DiviStanford$1.5M
- Mauro RuffySan Jose$124K
- Sarmela SunderLancaster$85K
- Ritvik MehtaCarlsbad$48K
- Jen ChowArcadia$26K
- Natee PoopatUpland$23K
- Ryan CasserlyMonterey$23K
- Alexis FurzeNewport Beach$16K
- Jahangir SharifiLos Angeles$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.